Temazepam is a medication of the benzodiazepine class which is generally used to treat severe or debilitating insomnia.
| FactSnippet No. 1,124,705 |
Temazepam is a medication of the benzodiazepine class which is generally used to treat severe or debilitating insomnia.
| FactSnippet No. 1,124,705 |
Temazepam is rapidly absorbed, and significant hypnotic effects begin in less than 30 minutes and can last for up to eight hours.
| FactSnippet No. 1,124,706 |
Temazepam was patented in 1962 and came into medical use in 1969.
| FactSnippet No. 1,124,707 |
Temazepam had the highest rate of drug intoxication, including overdose, among common benzodiazepines in cases with and without combination with alcohol in a 1985 study.
| FactSnippet No. 1,124,708 |
Temazepam was synthesized in 1964, but it came into use in 1981 when its ability to counter insomnia was realized.
| FactSnippet No. 1,124,709 |
Temazepam is a drug with a high potential for misuse.
| FactSnippet No. 1,124,710 |
Temazepam is a Schedule 4 drug and requires a prescription.
| FactSnippet No. 1,124,711 |
Temazepam was the most commonly used benzodiazepine in a study, published 1994, of injecting drug users in seven cities, and had been injected from preparations of capsules, tablets, and syrup.
| FactSnippet No. 1,124,712 |
Temazepam use was particularly associated with violent or disorderly behaviours and contact with the police in a 1997 study of young single homeless people in Scotland.
| FactSnippet No. 1,124,713 |
Temazepam is available in English-speaking countries under the following brand names:.
| FactSnippet No. 1,124,715 |
Temazepam is banned in Sweden and possession and distribution of even small amounts is punishable by a prison sentence and a fine.
| FactSnippet No. 1,124,716 |
Temazepam requires safe custody and up until June 2015 was exempt from CD prescription requirements.
| FactSnippet No. 1,124,717 |